These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 6854471)

  • 1. Biochemical effects of thiabendazole and cambendazole on Hymenolepis diminuta (Cestoda) in vivo.
    McCracken RO; Taylor DD
    J Parasitol; 1983 Apr; 69(2):295-301. PubMed ID: 6854471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of benzothiazole and benzimidazole anthelmintics: a molecular modeling approach to in vivo drug efficacy.
    McCracken RO; Lipkowitz KB
    J Parasitol; 1990 Dec; 76(6):853-64. PubMed ID: 2254820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effect of albendazole, cambendazole, and thiabendazole on the larval development of three hymenolepidid cestodes.
    Evans WS; Hardy M; Novak M
    J Parasitol; 1980 Dec; 66(6):935-40. PubMed ID: 7218116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water balance and its relation to fermentation acid production in the intestinal parasites Hymenolepis diminuta (Cestoda) and Moniliformis moniliformis (Acanthocephala).
    Uglem GL
    J Parasitol; 1991 Dec; 77(6):874-83. PubMed ID: 1779290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of host feeding and available glucose on glycogen synthase and phosphorylase activities in Hymenolepis diminuta and Vampirolepis microstoma.
    Wages SE; Roberts LS
    J Parasitol; 1990 Dec; 76(6):796-804. PubMed ID: 2123923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of praziquantel on Hymenolepis diminuta in vitro.
    Andrews P; Thomas H
    Tropenmed Parasitol; 1979 Sep; 30(3):391-400. PubMed ID: 543005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling: a tool for predicting anthelmintic activity in vivo.
    Lipkowitz KB; McCracken RO
    Parasitol Res; 1993; 79(6):475-9. PubMed ID: 8415561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthelmintic-induced destrobilation and its influence on calculated drug efficacy in Hymenolepis diminuta infections in rats.
    Dixon BR; Arai HP
    J Parasitol; 1991 Oct; 77(5):769-74. PubMed ID: 1919927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical effects of fenbendazole on Hymenolepis diminuta in vivo.
    McCracken RO; Taylor DD
    Int J Parasitol; 1983 Jun; 13(3):267-72. PubMed ID: 6874227
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental and theoretical studies of albendazole, oxibendazole, and tioxidazole.
    McCracken RO; Lipkowitz KB
    J Parasitol; 1990 Apr; 76(2):180-5. PubMed ID: 2319417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectivity of Hymenolepis diminuta for the jird, Meriones unguiculatus, and utility of this model for anthelmintic studies.
    Johnson SS; Conder GA
    J Parasitol; 1996 Jun; 82(3):492-5. PubMed ID: 8636859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hymenolepis pseudodiminuta Tenora et al. 1994 from Apodemus speciosus and H. diminuta: a comparison of experimental infections in rats.
    Ishih A; Sekijima T; Asakawa M; Tenora F; Uchikawa R
    Parasitol Res; 2003 Mar; 89(4):297-301. PubMed ID: 12632167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible biochemical mode of action for benzimidazole anthelmintics.
    McCracken RO; Stillwell WH
    Int J Parasitol; 1991 Feb; 21(1):99-104. PubMed ID: 2040571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled tests of activity of several antiparasitic compounds against natural infections of Haemonchus contortus and other helminths in lambs from a flock established in 1962.
    Lyons ET; Drudge JH; Tolliver SC; Stamper S
    Am J Vet Res; 1993 Mar; 54(3):406-10. PubMed ID: 8498743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effects of putative crowding factors on development of Hymenolepis diminuta.
    Cook RL; Roberts LS
    J Parasitol; 1991 Feb; 77(1):21-5. PubMed ID: 1846915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of albendazole and mebendazole against Hymenolepis microstoma and Hymenolepis diminuta.
    McCracken RO; Lipkowitz KB; Dronen NO
    Parasitol Res; 1992; 78(2):108-11. PubMed ID: 1557321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hymenolepis diminuta: effects of amoscanate on energy metabolism and ultrastructure.
    Nelson NF; Saz HJ
    Exp Parasitol; 1983 Aug; 56(1):55-69. PubMed ID: 6409659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hymenolepis diminuta: praziquantel removal of adult tapeworms is followed by apoptotic down-regulation of mucosal mastocytosis.
    Starke WA; Oaks JA
    Exp Parasitol; 1999 Jul; 92(3):171-81. PubMed ID: 10403758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hymenolepis diminuta-golden hamster (Mesocricetus auratus) model for the evaluation of gastrointestinal anticestode activity.
    Ostlind DA; Mickle WG; Smith SK; Cifelli S; Ewanciw DV
    J Parasitol; 2004 Aug; 90(4):898-9. PubMed ID: 15357098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.